TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: proportion of patients with oropharyngeal gram-negative colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in nocturnal systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the unified parkinson's disease rating scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protective Efficacy after CHMI with PfSPZ Challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor power improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Positive for PH Biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Positive for PH by Cardiac MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of Biomarker Signatures in Terms of Sensitivity, Specificity, PPV, and NPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of plasma interleukin (IL)-6 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maxillary and mandibular inter-first permanent molar distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maxillary and mandibular dental arches perimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palatal depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Change in Low Density Lipoprotein - Cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of HIV-specific Total IgG Binding Antibody Response Elicited by the CH505TF gp120 Proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in patient's medication appropriateness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in patient quality of life after deprescribing intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in severity of neuropsychiatric symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Microcirculatory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IEL characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent fat after 16 weeks treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Central Subfield Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate (bpm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal rate of oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventricular performance assessed by cardiac stress MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of laser treatments
Endpoint domain: Resource use
Primary endpoint: Summed Pain Intensity Difference at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in PASI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With 75% Reduction in PASI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of unintended pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: Immunogenicity of Inflexal V
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cognitive flexibility performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device- or procedure-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in International Index of Erectile Function scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to Opening of Eyes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Red Blood Cell Post-filtration Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Residual Leukocyte Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: radiological progression of bone fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rotational stability of SISA monofocal implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: overall cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vancouver Scar Scale results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Tumour-related alterations in circulating DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial Fibrillation Burden (AFB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: volume and CE in the PLN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crying length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients undergoing Intact procedure with diagnosis upgrade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Presence of Gd-deposit associated brain signal alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Phase II recommended dose (P2RD) of Vorinostat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Subjects Experiencing Solicited Local and Systemic Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Subjects Experiencing Unsolicited Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Subjects Experiencing Unsolicited Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Clinical Definite Multiple Sclerosis (CDMS)
Endpoint domain: Mortality/survival
Primary endpoint: Interface pressure in the sacral zone (mm Hg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Mean Sensor Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Sensor Glucose Levels Between 71-120 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose Variability Measure: Coefficient of Variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: adverse post-stenting results
Endpoint domain: Adverse events/effects
Primary endpoint: Cerebral autoregulatory indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Completion of five-dose Essen rabies vaccine regimen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to scheduled date of five-dose Essen rabies vaccine regimen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety of AADC Gene Transfer
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Confirmed HIV-1 Infections
Endpoint domain: Adverse events/effects
Primary endpoint: fMRI BOLD activity during food wanting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbial alpha and beta diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum alkaline phosphatase (ALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical Mucus Score (CMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of arterial oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hospital for Special Surgery Knee Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain VAS Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in glycated hemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in LDL Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: severity of Stress Urinary Incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean Pain Intensity on Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transit time in the GI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Oxygenation (P/F ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vaccine coverage (dose 1)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Vaccine coverage (dose 2)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Consulting general practitioner or dermatologist
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Celiac disease diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paliperidone Pre-dose Plasma Concentration (Cpredose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Paliperidone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) Score
Endpoint domain: Adverse events/effects
Primary endpoint: Total number of lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Lymph node ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Vision gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plasma Pentraxin 3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Glycosylated Hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Standard Deviation (SD) of touch time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct sequence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of Sudden Cardiac Death or haemodynamically significant ventricular arrhythmia
Endpoint domain: Mortality/survival
Primary endpoint: Muscular oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Partial Pressure of Oxygen/ Fraction of Inspired Oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: End Expiratory Lung Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: differences in protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in motor performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinetic and kinematic gait analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self Reported Adherence to TKIs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Electronically Verified TKI Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: IAPCC-SV Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time-interval weighted summed pain intensity (SPI) with activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinical Global Impression (CGI) Severity of Illness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SPIGELMAN severity score of duodenal lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of HT on nocturnal frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Catheterization Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Estimated Bone Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blastocyst immediate survival
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of Device Failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPID24 (NRS pain/soreness on movement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visualization of biliary ducts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: number of patients with hypersensitivity reactions to rASNase
Endpoint domain: Adverse events/effects
Primary endpoint: Percent change from baseline in total cholesterol, LDL-C, HDL-C, and triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Symptoms free distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ABI - Ankle-Brachial Index Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EQ-5D quality of life measures
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: HS CRP levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Inflammatory cytokines in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Liver function levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glutathione peroxidase (GSH-Px) levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with recurrent lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in bladder sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in ice water test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change of Main Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical healing of fistula in ano
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Binge-eating episodes (EDE scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average daytime systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Validated Visual analogue scale for foot and ankle (VAS FA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Bone Mineral Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline: Liebowitz Social Anxiety Scale-Self report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline: Fear of Negative Evaluation Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Wound healing status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient reported outcome measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in liver fat content (hepatic steatosis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscular co-activations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EuroQOL 5 Dimensions EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sheehan Disability Scale (SDS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change of Brillouin frequency shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores on PHQ9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scores on PAM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preferences for pain treatment attributes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hospitalization Rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Emergency Department Visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Objective intracranial response rate (OIRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of subjective health complaints
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Summary of Change From Baseline in Fasted Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Summary of Maximum Plasma Concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: activities of daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: distance activities and mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Brief Assessment of Mealtime Behavior In Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional lower extremity muscular endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper extremity muscular endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbial keratitis incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: therapeutic effects of far infrared radiation on bipolar condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Lumbar Spine Bone Mineral Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of hospital acquired infections
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Contrast Media Volume Saved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Strengths and Difficulties Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Sites Developing an Injection Site Reaction (ISR) 24 Hours After Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Sites Developing an Injection Site Reaction (ISR) 48 Hours After Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Scores of Reaction After Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in symptom severity and functional status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline Fibroblast Growth Factor 21 (FGF21)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Range of Motion in Lumbar Spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain management effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proliferative capacity of T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infants' physical health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titre (GMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pathologic findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Rating of Overall Comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants who consented to take part as percentage of those who expressed initial interest
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Actual attendance at each session as percentage of expected attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who provided completed questionnaire measures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Postural Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in reaction time with functional arm reach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum levels of Interleukin 6 (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Extended Release Epidural Morphine (EREM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in abdominal aortic aneurysm anteroposterior diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Drusen volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes